Immunotherapy has recently emerged as a promising approach to cancer treatment, ideally leading us toward a deeper understanding of cancer and how to treat it. With the convergence of bioinformatics data, combined therapy approaches and viable new pathways to explore, there is a sense that we are at the beginning of a new era in cancer drug discovery and facing several questions: How do we accelerate the immunotherapy discovery process? Can we achieve patient-specific treatments through bioinformatics? How do we prevent tumors from developing resistance to immunotherapies? How can we avoid toxicity associated with immunotherapies, and what are the safety considerations?
Join Charles River in Munich as leading scientists discuss how they are guiding their programs in this new era and how the field is responding to answer these questions.
This complimentary symposium, sponsored by Charles River, includes lunch, and refreshment breaks throughout the day as well as a networking reception after the symposium.
November 28, 2016 10:00 AM - 6:00 PM
Holiday Inn Munich - City CentreHochstrasse 3Munich 81669Germany
Get Driving Directions
Cvent Online Event Registration Software | Copyright © 2000-2016 Cvent, Inc. All rights reserved.